Stage IIIA Colon Cancer AJCC v8

specific

Stage IIIA includes: (T1-T2, N1/N1c, M0); (T1, N2a, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. N1: Metastasis in 1-3 regional lymph nodes. N1c: Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional lymph node metastasis. N2a: Metastasis in 4-6 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.)

38

Centers

31

Active Trials

Cancer Funding

Top Centers for Stage IIIA Colon Cancer AJCC v8(38)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
73.2
2
NCI Comprehensive
Active Research Program
55.5
3
NCI Comprehensive
Active Research Program
55.5
4
NCI Comprehensive
Active Research Program
55.5
5
NCI Comprehensive
Active Research Program
55.5
6
NCI Comprehensive
Active Research Program
55.5
7
NCI Comprehensive
Active Research Program
55.5
8
NCI Comprehensive
Active Research Program
55.5
9
NCI Comprehensive
Active Research Program
55.5
10
NCI Comprehensive
Active Research Program
55.5
11
NCI Comprehensive
Active Research Program
55.5
12
NCI Comprehensive
Active Research Program
55.5
13
NCI Comprehensive
Active Research Program
55.5
14
NCI Comprehensive
Active Research Program
55.5
15
NCI Clinical
Active Research Program
55.5
16
NCI Comprehensive
Active Research Program
55.5
17
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
55.5
18
NCI Comprehensive
Active Research Program
55.5
19
NCI Comprehensive
Active Research Program
55.5
20
NCI Clinical
Active Research Program
55.5
21
NCI Comprehensive
Active Research Program
55.5
22
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
55.5
23
NCI Clinical
Active Research Program
55.5
24
Active Research Program
55.5
25
Active Research Program
55.5
26
Active Research Program
55.5
27
Active Research Program
55.5
28
Active Research Program
55.5
29
Active Research Program
55.5
30
Active Research Program
55.5
31
NCI Comprehensive
33.6
32
NCI Comprehensive
33.6
33
NCI Comprehensive
33.6
34
NCI Comprehensive
33.6
3533.6
3633.6
37
NCI Comprehensive
33.6
38
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
33.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →